Answers are grounded in this paper and cite their sources.
Triple-negative breast cancer (TNBC) remains an aggressive malignancy, largely due to its resistance to conventional apoptosis-inducing therapies and induction of survival autophagy, making the identification of novel cell death mechanisms critical. Piperlongumine (PL), an alkaloid derived from Piper longum, has shown promising anti-cancer activity, yet its ability to induce paraptosis and inhibit autophagy in TNBC has not been explored. In this study, PL-induced cell death was investigated through morphological analysis, cell viability assays, Annexin-V/PI staining, ER stress marker assessment, autophagic flux using a tandem fluorescence construct, and pharmacological inhibition with NAC, chloroquine, cycloheximide, and MAPK inhibitors, alongside ALIX knockdown and overexpression studies to clarify the regulatory mechanism. Survival analyses based on ALIX expression were also conducted using three independent public transcriptomic datasets. PL induced higher cytotoxicity in TNBC cells than in MCF-10A, through cytoplasmic vacuolation-mediated paraptosis, with vacuoles originating from the ER alongside elevated ER stress, polyubiquitinated protein accumulation, Bip/CHOP upregulation, mitochondrial dysfunction, increased ROS, and reduced ATP. PL-induced cell death was suppressed by NAC, implicating sulfhydryl disruption. PL impaired late-stage autophagy, evidenced by LC3-II/p62 accumulation, and downregulated ALIX, whose overexpression restored survival and reduced paraptosis. High ALIX expression predicted poor basal/TNBC prognosis in two of three cohorts, suggesting therapeutic significance.
No takes yet. Share an insight, caveat, or question.
Hanson et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: